DFine Announces Full U.S. Commercial Release of STAR Tumor Ablation System

Published: Sep 18, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the full commercial U.S. launch of the STAR™ Tumor Ablation System. The announcement marks the nationwide release of the STAR System and percutaneous targeted Radiofrequency Ablation™ (t-RFA) therapy, which allows physicians to provide patients with rapid pain relief from metastatic spinal tumors in a single, minimally invasive treatment.

Back to news